Creating new chiral molecules using organoboron compounds
Asymmetric Synthesis via Organoboron Compounds
This study is exploring new ways to create special molecules that are important for medicines and farming, using a unique type of chemical called organoboron to make them more pure and efficient, which could help improve drug development and make medications work better for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Virginia Polytechnic Inst and St Univ NIH-funded |
| Lab location | 1 site (Blacksburg, United States) |
| Project ID | NIH-10892797 on NIH RePORTER |
What this research studies
This research focuses on developing new methods to synthesize chiral molecules, which are essential for various applications in medicine and agriculture. By utilizing organoboron compounds, the researchers aim to create these molecules with high purity and efficiency. The project involves innovative catalytic processes that leverage the unique properties of boron to facilitate the formation of complex chemical structures. This work is significant for improving drug discovery and enhancing the effectiveness of pharmaceutical products.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals involved in drug development or those with conditions that could be treated by new pharmaceutical compounds derived from chiral molecules.
Not a fit: Patients who are not involved in drug development or do not have conditions that could be addressed by new chiral drugs may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective drugs and agrochemicals, improving health outcomes and agricultural productivity.
How similar studies have performed: Previous research has shown promise in using organoboron compounds for asymmetric synthesis, indicating that this approach has potential for success.
Where this research is happening
Blacksburg, United States
- Virginia Polytechnic Inst and St Univ — Blacksburg, United States (Active)
Researchers
- Principal investigator: Chen, Ming — Virginia Polytechnic Inst and St Univ
- Study coordinator: Chen, Ming
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.